Novartis AG
NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
$161.52+0.73 (+0.45%)
Close on Nov 2, 2026Market cap $308.21BP/E 22.6Yield –
Novartis Basic Shares (million shares): 1,896M in Q3 2026, down 1.6% from a year earlier. That is the lowest of the 37 quarters on record here.
Latest, Q3 2026
1,896
Period ended Sep 30, 2026
Change on a year earlier
-1.6%
1,926 in Q3 2025
History
37 quarters
Since Q2 2017
Sources
33
Documents cited below
Where the Q3 2026 figure comes from
“|| Weighted average number of shares outstanding – Basic (million) | 1 896 | 1 926”
Source: Novartis Form 6-K (0001114448-26-000014) ↗
Reported in Postgres DB + Form 6-K.
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Cite this data
StockData. (2026). Novartis Basic Shares (million shares) (M), quarterly Q2 2017–Q3 2026 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/db-is-shares-basic
See every metric in the Novartis KPI table. Data updated Nov 2, 2026.